Literature DB >> 16156865

Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method.

G Stussi1, K Huggel, H U Lutz, U Schanz, R Rieben, J D Seebach.   

Abstract

Several methods to detect anti-A/B antibodies based on haemagglutination and haemolysis have been described. These methods measure predominantly anti-A/B immunoglobulin (Ig)M, whereas anti-A/B IgG and IgG subclasses are less well examined. We established a flow cytometry method (ABO-fluorescence-activated cell sorting; ABO-FACS) to quantify binding of anti-A/B IgM, IgG and IgG subclasses to human A or B red blood cells. Anti-A/B IgM were present in the majority of 120 blood donors, as expected from blood group typing. The sensitivity and specificity of anti-A/B IgM to predict the blood group was 93% and 96% respectively. Anti-A/B IgG was found in 34/38 blood group O samples (89%). Anti-B IgG in blood group A or anti-A IgG in blood group B was present in 4/28 (14%) and 1/28 (4%) samples, respectively, and absent in 26 AB sera. IgG2 was the predominant IgG subclass. The correlation of anti-A/B IgM and IgG in the ABO-FACS with haemagglutination titres was 0.870 and 0.783, respectively (n = 240; P < 0.001) whereas the comparison of ABO-FACS with ABO-enzyme-linked immunosorbent assay was less significant. In conclusion, ABO-FACS is a valid method to quantify anti-A/B IgM, IgG and IgG subclasses. It opens the possibility of isotype-specific monitoring of anti-A/B antibodies levels after ABO-incompatible solid organ and stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156865     DOI: 10.1111/j.1365-2141.2005.05705.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

1.  Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

Authors:  Francis Jacob; Darlene R Goldstein; Nicolai V Bovin; Tatiana Pochechueva; Marianne Spengler; Rosemarie Caduff; Daniel Fink; Marko I Vuskovic; Margaret E Huflejt; Viola Heinzelmann-Schwarz
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

2.  Serological correlate of protection against norovirus-induced gastroenteritis.

Authors:  Amanda Reeck; Owen Kavanagh; Mary K Estes; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  Outcomes of ABO-incompatible kidney transplantation in the United States.

Authors:  John R Montgomery; Jonathan C Berger; Daniel S Warren; Nathan T James; Robert A Montgomery; Dorry L Segev
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

4.  A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity.

Authors:  Hee-Jeong Youk; Ho-Yoon Ryu; Suk Won Seo; Jin Seok Kim; Yousun Chung; Hyungsuk Kim; Sang-Hyun Hwang; Heung-Bum Oh; Won-Ki Min; Dae-Hyun Ko
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

Review 5.  Laboratory support of ABO antibody monitoring for ABO-incompatible solid organ transplantation.

Authors:  Yousun Chung; Dae-Hyun Ko
Journal:  Korean J Transplant       Date:  2022-05-24

6.  Ascites analysis by a microfluidic chip allows tumor-cell profiling.

Authors:  Vanessa M Peterson; Cesar M Castro; Jaehoon Chung; Nathan C Miller; Adeeti V Ullal; Maria D Castano; Richard T Penson; Hakho Lee; Michael J Birrer; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 7.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

Review 8.  ABO incompatible renal transplants: Good or bad?

Authors:  Masaki Muramatsu; Hector Daniel Gonzalez; Roberto Cacciola; Atsushi Aikawa; Magdi M Yaqoob; Carmelo Puliatti
Journal:  World J Transplant       Date:  2014-03-24

9.  Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies.

Authors:  Tatiana Pochechueva; Francis Jacob; Darlene R Goldstein; Margaret E Huflejt; Alexander Chinarev; Rosemarie Caduff; Daniel Fink; Neville Hacker; Nicolai V Bovin; Viola Heinzelmann-Schwarz
Journal:  Glycoconj J       Date:  2011-09-23       Impact factor: 2.916

10.  TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.

Authors:  Xiaojie Yu; Sonya James; James H Felce; Blanka Kellermayer; David A Johnston; H T Claude Chan; Christine A Penfold; Jinny Kim; Tatyana Inzhelevskaya; C Ian Mockridge; Yasunori Watanabe; Max Crispin; Ruth R French; Patrick J Duriez; Leon R Douglas; Martin J Glennie; Mark S Cragg
Journal:  Commun Biol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.